The cofounders of startup that is looking to develop a vaccine for HPV are heading to a Buffalo accelerator.
PathoVax is among the new class of startups at 43North. A panel of judges and experts selected them as finalists after a big, fancy pitch competition held in late October meant to showcase Buffalo’s emerging tech chops.
{iframe}http://technical.ly/baltimore/2016/11/11/pathovax-43north-buffalo-jhu/{/iframe}